相关实验视频

Updated: Jun 18, 2025

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

基因组规模的CRISPR-Cas9屏幕识别了宿主因素作为SARS-CoV-2感染的潜在治疗点

Madoka Sakai¹, Yoshie Masuda², Yusuke Tarumoto²

¹Laboratory of RNA Viruses, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto 6068507, Japan.

|August 5, 2024

概括

研究人员确定了促进SARS-CoV-2感染的TRIM28和EHMT1/2等宿主因素. 用UNC0642抑制EHMT1/2降低了病毒生长和疾病严重程度,这表明EHMT1/2是COVID-19的潜在治疗标.

科学领域:

病毒学病毒学
分子生物学分子生物学
宿主-病原体相互作用

背景情况:

了解宿主因素对于对抗SARS-CoV-2至关重要.
SARS-CoV-2 与宿主细胞相互作用的机制需要进一步阐明.

研究的目的:

为了识别宿主前病毒因素对于SARS-CoV-2感染至关重要.
调查已识别的因素在病毒生命周期中的作用.
评估EHMT1/2作为COVID-19的潜在治疗标.

主要方法:

通过CRISPR-Cas9查来识别宿主前病毒因素.
在体外细胞培养实验中评估病毒复制.
在体内研究使用仓鼠感染模型来评估疾病严重程度.

主要成果:

确定了TRIM28,TRIM33,EHMT1和EHMT2作为前病毒因素.
似乎TRIM28参与病毒颗粒的形成.
TRIM33,EHMT1和EHMT2都与病毒转录和复制有关.
在实验室中,EHMT1/2抑制剂UNC0642显著抑制了SARS-CoV-2的生长.
治疗UNC0642在仓鼠模型中降低了疾病的严重程度.

结论:

EHMT1和EHMT2是SARS-CoV-2复制的关键宿主因素.
用像UNC0642这样的抑制剂准EHMT1/2甲基转移酶活性显示出对SARS-CoV-2的治疗潜力.
EHMT1/2代表了COVID-19治疗的有前途的治疗标.

关键词:

细胞生物学细胞生物学分子生物学分子生物学病毒学病毒学

更多相关视频

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...